Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (561) 561
Patent (480) 480
Publication (152) 152
Book Chapter (16) 16
Book Review (6) 6
Conference Proceeding (5) 5
Book / eBook (4) 4
Newsletter (4) 4
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (470) 470
hygiene (466) 466
medical or veterinary science (466) 466
preparations for medical, dental, or toilet purposes (464) 464
chemistry (459) 459
metallurgy (458) 458
microbiology (441) 441
biochemistry (426) 426
beer (417) 417
enzymology (417) 417
mutation or genetic engineering (417) 417
spirits (417) 417
vinegar (417) 417
wine (417) 417
compositions thereof (411) 411
culture media (411) 411
microorganisms or enzymes (411) 411
propagating, preserving or maintaining microorganisms (411) 411
peptides (368) 368
organic chemistry (365) 365
humans (274) 274
animals (208) 208
specific therapeutic activity of chemical compounds ormedicinal preparations (203) 203
index medicus (144) 144
viruses (109) 109
mice (103) 103
virology (97) 97
immunology (88) 88
vaccines (88) 88
research (87) 87
hiv-1 - immunology (86) 86
female (77) 77
multidisciplinary sciences (77) 77
hiv (76) 76
molecular sequence data (74) 74
medicine, research & experimental (72) 72
aids vaccines - immunology (69) 69
vaccination (69) 69
article (63) 63
antibodies (60) 60
genetic vectors (58) 58
infection (58) 58
cell biology (56) 56
male (56) 56
cell line (55) 55
hiv-1 - genetics (55) 55
proteins (55) 55
dna (54) 54
identification (54) 54
physics (53) 53
biochemistry & molecular biology (52) 52
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (52) 52
testing (52) 52
general tagging of cross-sectional technologies spanning over several sections of the ipc (51) 51
general tagging of new technological developments (51) 51
hiv infections - immunology (51) 51
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (51) 51
technologies for adaptation to climate change (51) 51
technologies or applications for mitigation or adaptation againstclimate change (51) 51
base sequence (50) 50
investigating or analysing materials by determining theirchemical or physical properties (50) 50
measuring (50) 50
mice, inbred balb c (50) 50
virus diseases (50) 50
infections (49) 49
immunization (48) 48
vaccines, dna - immunology (48) 48
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (46) 46
disinfection, sterilisation, or deodorisation of air (46) 46
expression (46) 46
materials for bandages, dressings, absorbent pads, or surgicalarticles (46) 46
methods or apparatus for sterilising materials or objects ingeneral (46) 46
aids vaccines (45) 45
diagnosis (44) 44
hiv antibodies - immunology (43) 43
hiv infections - prevention & control (43) 43
surgery (43) 43
transfection (43) 43
immunogenicity (42) 42
immunity (41) 41
infectious diseases (41) 41
plasmids (41) 41
t-lymphocytes - immunology (40) 40
neutralizing antibodies (39) 39
processes using microorganisms (39) 39
vaccines and antiviral agents (39) 39
adenoviridae - genetics (38) 38
antibodies, neutralizing - immunology (37) 37
gene expression (37) 37
medical research (37) 37
research article (37) 37
aids (35) 35
gene transfer techniques (35) 35
human immunodeficiency virus--hiv (35) 35
t lymphocytes (35) 35
amino acid sequence (34) 34
cells (34) 34
cells, cultured (34) 34
antigens (33) 33
adult (32) 32
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1028) 1028
French (222) 222
German (89) 89
Spanish (15) 15
Chinese (12) 12
Portuguese (7) 7
Danish (4) 4
Korean (3) 3
Japanese (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text GLOBAL HEALTH Designing Tomorrow's Vaccines
by Nabel, GJ
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2013, Volume 368, Issue 6, pp. 551 - 560
  Vaccines are some of the most cost-effective treatments in medicine. This article reviews new strategies being applied to develop vaccines for diseases that... 
MEDICINE, GENERAL & INTERNAL | POTENT | VIRUS-VACCINES | HIV VACCINE | CELLULAR-IMMUNITY | PROTECTION | BROADLY NEUTRALIZING ANTIBODIES | CLINICAL-TRIALS | INFLUENZA VACCINE | SIV INFECTION | RATIONAL DESIGN | Licenses | Smallpox | Infections | Tuberculosis | Vaccines | Malaria
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Designing Tomorrow's Vaccines
by Nabel, Gary J
The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 6, pp. 551 - 560
Vaccines are some of the most cost-effective treatments in medicine. This article reviews new strategies being applied to develop vaccines for diseases that... 
Licensure - history | History, 21st Century | Communicable Diseases - epidemiology | Dendritic Cells - immunology | History, 20th Century | Humans | Translational Medical Research | Antibodies, Neutralizing - genetics | Clinical Trials as Topic | Host-Pathogen Interactions - drug effects | Vaccines - history | Communicable Disease Control | Allergy and Immunology - history | Antibodies, Neutralizing - chemistry | Drug Design | History, 19th Century | Vaccines - administration & dosage | Evolution, Molecular | Usage | Supply and demand | Immune response | Vaccination | Forecasts and trends | Research | Vaccines | Drug discovery | Methods | Infection control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Vaccinate for the next H2N2 pandemic now: an old influenza strain still circulating in birds and swine could easily jump back to humans now that immunity to it has dropped, warn Gary J. Nabel and his colleagues
by Nabel, Gary J
Nature, ISSN 0028-0836, 03/2011, Volume 469, Issue 7337, p. 157
Influenza viruses | Prevention | Influenza vaccines | Epidemics | Control | United States | Product development | Management | Natural history
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text All for one and one for all to fight flu
by Nabel, Gary J and Nabel, Gary J and Shiver, John W
Nature, ISSN 0028-0836, 01/2019, Volume 565, Issue 7737, pp. 29 - 31
Antibodies have been engineered to recognize diverse strains of influenza, including both the A and B types of virus that cause human epidemics. Are we moving... 
Medical research | Virology | INFLUENZA | ANTIBODY | HEMAGGLUTININ-STEM | PROTECTION | MULTIDISCIPLINARY SCIENCES | Influenza viruses | Prevention | Viral antibodies | Antibodies | Medicine, Experimental | Research | Influenza vaccines | Influenza | Antiviral agents | Immunoglobulins | Pandemics | Medical treatment | Health risks | Science | Viruses | Infections | Vaccines | Drug development | Gene expression | Proteins | Infectious diseases | Older people | Influenza A | Children | In vitro methods and tests | Strains (organisms) | Influenza B | Neutralization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Firepower in the lab : automation in the fight against infectious diseases and bioterrorism
by Beugelsdijk, Tony J., 1949 and Layne, Scott P and Patel, C. Kumar N
2001, ISBN 0309068495, ix, 299
Medicine | Automation | Congresses | Medical laboratories | Laboratories | United States | Research | Technological innovations | Bioterrorism
Book
Details down arrow
6. Full Text Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 + T cells is directly associated with the magnitude of surface igg binding
by Smalls-Mantey, Adjoa and Doria-Rose, Nicole and Klein, Rachel and Patamawenu, Andy and Migueles, Stephen A and Ko, Sung-Youl and Hallahan, Claire W and Wong, Hing and Liu, Bai and You, Lijing and Scheid, Johannes and Kappes, John C and Ochsenbauer, Christina and Nabel, Gary J and Connors, John R. Mascola
Journal of Virology, ISSN 0022-538X, 08/2012, Volume 86, Issue 16, pp. 8672 - 8680
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25–27 October 2015
by Girard, Marc P and Le-Grand, Roger and Picot, Valentina and Longuet, Christophe and Nabel, Gary J
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 31, pp. 3557 - 3561
Abstract The 2015 Cent Gardes Conference on HIV vaccines took place on October 25–27 at the Merieux Foundation Conference Center in Veyrier du Lac, near... 
Allergy and Immunology | Mucosal immunity | HIV | B cell lineage | Neutralizing antibodies | Passive immunization | ADCC | HIV Infections - prevention & control | Antibodies, Neutralizing - immunology | Congresses as Topic | Animals | HIV Antibodies - immunology | Immunity, Humoral | Humans | AIDS Vaccines - immunology | Antibody Formation | Immunization, Passive | France | Prevention | AIDS vaccines | HIV (Viruses) | Convention facilities | Vaccination | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Infections | Vaccines | Mutation | Viral infections | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression
by Boehm, M and Yoshimoto, T and Crook, MF and Nallamshetty, S and True, A and Nabel, GJ and Nabel, EG
EMBO JOURNAL, ISSN 0261-4189, 07/2002, Volume 21, Issue 13, pp. 3390 - 3401
The cyclin-dependent kinase inhibitor, p27(Kip1), which regulates cell cycle progression, is controlled by its subcellular localization and subsequent... 
p27(Kip1) | serine | COMPLEX | PROTEIN | cell cycle | RNA-RECOGNITION MOTIF | BIOCHEMISTRY & MOLECULAR BIOLOGY | STATHMIN | UBIQUITIN-LIGASE | CELL BIOLOGY | INHIBITOR P27(KIP1) | P27 | S-PHASE | DEGRADATION | hKIS | phosphorylation | EXPRESSION | Phosphorylation | Growth Substances - blood | Humans | Cytoplasm - metabolism | 3T3 Cells - metabolism | RNA, Untranslated - genetics | Recombinant Fusion Proteins - metabolism | Cell Cycle Proteins - chemistry | Cell Nucleus - metabolism | Tumor Suppressor Proteins - chemistry | Blood Physiological Phenomena | Adult | Chromosomes, Human, Pair 1 - genetics | Culture Media, Serum-Free - pharmacology | Protein Structure, Tertiary | Cells, Cultured - drug effects | Tumor Suppressor Proteins - metabolism | Protein-Serine-Threonine Kinases - physiology | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Protein-Serine-Threonine Kinases - isolation & purification | Intracellular Signaling Peptides and Proteins | 3T3 Cells - drug effects | Phosphoserine - metabolism | Phosphothreonine - metabolism | Cyclin-Dependent Kinase Inhibitor p27 | Protein Transport | Animals | Cell Cycle - physiology | Growth Substances - pharmacology | Cells, Cultured - metabolism | Mice | Protein Processing, Post-Translational | RNA, Small Interfering
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Report of the 2014 Cent Gardes HIV Vaccine Conference—Part 2: Cell-mediated immunity, mucosal protection, and clinical trials
by Girard, Marc P and Picot, Valentina and Longuet, Christophe and Nabel, Gary J
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 33, pp. 4051 - 4055
Abstract The 2014 Cent Gardes Conference took place on October 5–7, 2014, at the Fondation Mérieux Conference Center, on the shores of the Annecy Lake and... 
Allergy and Immunology | AIDS vaccines | Conferences, meetings and seminars | Genetic vectors | Convention facilities | Clinical trials | Monkeys | HIV (Viruses) | Conferences and conventions | Cytomegalovirus | Lymphocytes | Human immunodeficiency virus--HIV | Mortality | Colleges & universities | Infections | Genomes | Vaccines | Mutation | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Designing Tomorrow’s Vaccines
by Nabel, Gary J
The New England journal of medicine, ISSN 0028-4793, 2/2013, Volume 368, Issue 6, pp. 551 - 560
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Norman L. Letvin (1949-2012)
by Gary J. Nabel and Steven M. Wolinsky and Barton F. Haynes
Science, ISSN 0036-8075, 6/2012, Volume 336, Issue 6089, pp. 1653 - 1653
He stood in thought, attentive to every detail, ready for his delivery. Well known for his clear and insightful presentations, Norman Letvin strode onstage... 
PERSPECTIVES | MULTIDISCIPLINARY SCIENCES | Deaths | Biomedical research | Personal profiles | Human immunodeficiency virus--HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
by Nabel, Gary J and Fauci, Anthony S
Nature Medicine, ISSN 1078-8956, 12/2010, Volume 16, Issue 12, pp. 1389 - 1391
The immune system normally responds to influenza virus by making neutralizing antibodies to regions of the viral spike, the hemagglutinin, that vary year to... 
A VIRUS | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | HEMAGGLUTININ | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICE | INFECTION | NEUTRALIZATION | CELL BIOLOGY | Genetic Variation | Antibodies, Monoclonal - genetics | Conserved Sequence - genetics | Cross Protection - genetics | Influenza Vaccines - immunology | Influenza Vaccines - genetics | Species Specificity | Hemagglutinins, Viral - genetics | Humans | Models, Molecular | Phylogeny | Evolution, Molecular | Viral antibodies | Influenza vaccines | Antibodies | Physiological aspects | Research | Immunity | Health aspects | Biomedical research | Vaccines | Molecular biology | Influenza | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
by Liao, Hua-Xin and Bonsignori, Mattia and Alam, S. Munir and McLellan, Jason S and Tomaras, Georgia D and Moody, M. Anthony and Kozink, Daniel M and Hwang, Kwan-Ki and Chen, Xi and Tsao, Chun-Yen and Liu, Pinghuang and Lu, Xiaozhi and Parks, Robert J and Montefiori, David C and Ferrari, Guido and Pollara, Justin and Rao, Mangala and Peachman, Kristina K and Santra, Sampa and Letvin, Norman L and Karasavvas, Nicos and Yang, Zhi-Yong and Dai, Kaifan and Pancera, Marie and Gorman, Jason and Wiehe, Kevin and Nicely, Nathan I and Rerks-Ngarm, Supachai and Nitayaphan, Sorachai and Kaewkungwal, Jaranit and Pitisuttithum, Punnee and Tartaglia, James and Sinangil, Faruk and Kim, Jerome H and Michael, Nelson L and Kepler, Thomas B and Kwong, Peter D and Mascola, John R and Nabel, Gary J and Pinter, Abraham and Zolla-Pazner, Susan and Haynes, Barton F
Immunity, ISSN 1074-7613, 01/2013, Volume 38, Issue 1, pp. 176 - 186
The RV144 HIV-1 trial of the canary pox vector (ALVAC-HIV) plus the gp120 AIDSVAX B/E vaccine demonstrated an estimated efficacy of 31%, which correlated... 
V1/V2 DOMAIN | NEUTRALIZING ANTIBODIES | EFFICACY TRIAL | GP41 | IMMUNODEFICIENCY-VIRUS TYPE-1 | REACTIVITY | INFECTION | GP120 | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | EPITOPES | HIV Antibodies - metabolism | Amino Acid Sequence | Peptides - chemistry | Humans | Peptides - immunology | AIDS Vaccines - immunology | Amino Acid Substitution - immunology | Molecular Sequence Data | Protein Binding - immunology | HIV Antibodies - chemistry | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Peptides - metabolism | HIV Antibodies - immunology | Protein Conformation | Molecular Docking Simulation | Antibodies, Monoclonal - metabolism | HIV Envelope Protein gp120 - chemistry | Antibodies, Monoclonal - immunology | Medical colleges | Analysis | Crystals | Monoclonal antibodies | Vaccines | T cells | HIV (Viruses) | Structure | Public health | Biopharmaceutics | Medical informatics | Proteins | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Viruses | Ligands | Infections | Binding sites
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
by Xueling Wu and Tongqing Zhou and Jiang Zhu and Baoshan Zhang and Ivelin Georgiev and Charlene Wang and Xuejun Chen and Nancy S. Longo and Mark Louder and Krisha McKee and Sijy O'Dell and Stephen Perfetto and Stephen D. Schmidt and Wei Shi and Lan Wu and Yongping Yang and Zhi-Yong Yang and Zhongjia Yang and Zhenhai Zhang and Mattia Bonsignori and John A. Crump and Saidi H. Kapiga and Noel E. Sam and Barton F. Haynes and Melissa Simek and Dennis R. Burton and Wayne C. Koff and Nicole A. Doria-Rose and Mark Connors and James C. Mullikin and Gary J. Nabel and Mario Roederer and Lawrence Shapiro and Peter D. Kwong and John R. Mascola and NISC Comparative Sequencing Progra and NISC Comparative Sequencing Program and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Science, ISSN 0036-8075, 9/2011, Volume 333, Issue 6049, pp. 1593 - 1602
Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used... 
Germ cells | Neutralizing antibodies | B lymphocytes | RESEARCH ARTICLES | Genomics | Alleles | Antibodies | Phylogenetics | Epitopes | HIV 1 | High throughput nucleotide sequencing | DESIGN | DOMAIN | EPITOPE | MULTIDISCIPLINARY SCIENCES | BROAD | DIVERSITY | GLYCOPROTEIN | GP120 | MONOCLONAL-ANTIBODIES | SELECTION | BREADTH | Antibody Specificity | Complementarity Determining Regions - genetics | Humans | Immunoglobulin Heavy Chains - chemistry | Molecular Sequence Data | Crystallography, X-Ray | HIV Antibodies - isolation & purification | HIV Envelope Protein gp120 - metabolism | Genes, Immunoglobulin Heavy Chain | HIV Envelope Protein gp120 - immunology | Immunoglobulin Light Chains - chemistry | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Immunoglobulin J-Chains - genetics | Base Sequence | HIV Envelope Protein gp120 - chemistry | Binding Sites | Immunoglobulin Heavy Chains - immunology | Immunoglobulin Light Chains - immunology | Amino Acid Sequence | Models, Molecular | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | Sequence Analysis, DNA | Antibodies, Neutralizing - isolation & purification | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | AIDS Vaccines | High-Throughput Nucleotide Sequencing | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | Mutation | Binding Sites, Antibody | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | X-ray crystallography | Immunoglobulins | Physiological aspects | Genetic aspects | HIV (Viruses) | Health aspects | Methods | ANTIBODIES | IMMUNITY | BASIC BIOLOGICAL SCIENCES | GENETICS | IMMUNOGLOBULINS | CRYSTAL STRUCTURE | CRYSTALLOGRAPHY | CHAINS | 60 APPLIED LIFE SCIENCES | FUNCTIONALS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
by Tongqing Zhou and Ivelin Georgiev and Xueling Wu and Zhi-Yong Yang and Kaifan Dai and Andrés Finzi and Young Do Kwon and Johannes F. Scheid and Wei Shi and Ling Xu and Yongping Yang and Jiang Zhu and Michel Nussenzweig and Joseph Sodroski and Lawrence Shapiro and Gary J. Nabel and John R. Mascola and Peter D. Kwong
Science, ISSN 0036-8075, 8/2010, Volume 329, Issue 5993, pp. 811 - 817
During HIV-1 infection, antibodies are generated against the region of the viral gp120 envelope glycoprotein that binds CD4, the primary receptor for HIV-1.... 
Polysaccharides | Immunoglobulins | Receptors | Hydrogen bonds | Neutralizing antibodies | RESEARCH ARTICLES | Genomics | Antibodies | Viruses | Infections | HIV 1 | INDIVIDUALS | SITE | ATTACHMENT | EPITOPE | MULTIDISCIPLINARY SCIENCES | HYPOTHESIS | GP120 ENVELOPE GLYCOPROTEIN | SURFACE | RECEPTOR | MATURATION | VACCINES | HIV Envelope Protein gp120 - genetics | Humans | Molecular Sequence Data | Crystallography, X-Ray | Neutralization Tests | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Molecular Mimicry | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Base Sequence | HIV Envelope Protein gp120 - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | CD4 Antigens - immunology | Antigenic Variation | Models, Molecular | Antibody Affinity | HIV Antibodies - chemistry | HIV-1 - immunology | CD4 Antigens - chemistry | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | AIDS Vaccines | Protein Conformation | Immunoglobulin Fab Fragments - immunology | Binding Sites, Antibody | CD4 Antigens - metabolism | Molecular biology | Human immunodeficiency virus--HIV | Crystal structure | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
by McLellan, Jason S and Pancera, Marie and Carrico, Chris and Gorman, Jason and Julien, Jean-Philippe and Khayat, Reza and Louder, Robert and Pejchal, Robert and Sastry, Mallika and Dai, Kaifan and O'Dell, Sijy and Patel, Nikita and Shahzad-Ul-Hussan, Syed and Yang, Yongping and Zhang, Baoshan and Zhou, Tongqing and Zhu, Jiang and Boyington, Jeffrey C and Chuang, Gwo-Yu and Diwanji, Devan and Georgiev, Ivelin and Do Kwon, Young and Lee, Doyung and Louder, Mark K and Moquin, Stephanie and Schmidt, Stephen D and Yang, Zhi-Yong and Bonsignori, Mattia and Crump, John A and Kapiga, Saidi H and Sam, Noel E and Haynes, Barton F and Burton, Dennis R and Koff, Wayne C and Walker, Laura M and Phogat, Sanjay and Wyatt, Richard and Orwenyo, Jared and Wang, Lai-Xi and Arthos, James and Bewley, Carole A and Mascola, John R and Nabel, Gary J and Schief, William R and Ward, Andrew B and Wilson, Ian A and Kwong, Peter D and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Nature, ISSN 0028-0836, 12/2011, Volume 480, Issue 7377, pp. 336 - 343
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody... 
SYSTEM | POTENT NEUTRALIZATION | DEXTRAN SULFATE | EPITOPE | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENVELOPE GLYCOPROTEIN | RECEPTOR | BINDING | T-CELLS | SOFTWARE | AIDS Vaccines - immunology | Glycopeptides - chemistry | Molecular Sequence Data | Antibody Affinity - immunology | Crystallography, X-Ray | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Glycopeptides - immunology | Antibody Specificity - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Protein Structure, Quaternary | Conserved Sequence | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | Binding Sites, Antibody - immunology | Models, Molecular | Glycosylation | Polysaccharides - immunology | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Amino Acid Motifs | HIV-1 - immunology | Immune Evasion | Hydrogen Bonding | Antigen-Antibody Complex - chemistry | Antibodies, Neutralizing - chemistry | Epitopes - chemistry | Antigen-Antibody Complex - immunology | Viral envelopes | Genetic aspects | Research | HIV (Viruses) | Structure | Binding sites (Biochemistry) | Proteins | Crystals | Vaccines | ANTIBODIES | AIDS VIRUS | BASIC BIOLOGICAL SCIENCES | AFFINITY | BIOLOGY | GLYCOPROTEINS | VULNERABILITY | ANTIGENS | IMMUNOLOGY | 60 APPLIED LIFE SCIENCES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights